COMFA Members will be entitled to complimentary registration for the COMFA/CS-COUSIN meeting.
Regular invitations will be sent out via the e-COST system containing the a discount code. If you have not received the code, please email cs-cousin@conferencecollective.co.uk with proof of your membership to receive the code.
On Friday, 24 September, the COMFA Management Committee will hold its annual meeting as well as a general meeting for all COMFA members. A training school on basic tools for the different aspects of evidence synthesis and COS development will also be organised.13:00 15:15 (including a 15 Minute break)
COMFA Management Committee Meeting
Closed Meeting
16:00 – 18:00
COMFA Annual Meeting Open to all COMFA members
AGENDA
1. Welcome to Participants
2. Verification of the presence of two-thirds of the Participating COST Countries or, if applicable, a quorum
3. Approval of minutes and matters arising of last meeting
4. Current and completed projects
5. Immunological outcomes of allergen-specific immunotherapy in food allergy
6. Outcomes reported in clinical trials of IgE-mediated food allergy: A Systematic Review
7. Non-IgE-mediated Food Allergies: Reporting Measured Outcomes in Published Clinical Trials
8. Final review of the COS development protocol
9. VMs, VNS
10. Prospective projects
Tuesday 28 September
17:00 - 17:15: Contributing to feedback presentations from participating Groups
Speaker: Daniel Munblit
CS COUSIN and COMFA Joint Meeting
c/o The Conference Collective Ltd
8 Waldegrave Road
Teddington, Middlesex
TW11 8HT, UK
CS-Cousin@conferencecollective.co.uk
+44 (0) 20 8977 7997
This meeting is co-organised and partly funded by the COST Action COMFA CA18227, supported by COST (European Cooperation in Science and Technology)
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.